Permutive raises £14m in Series B funding led by Octopus Ventures to scale international operations and product development.
The publisher-focused data platform has secured £14m from Octopus Ventures and EQT Ventures to drive North American expansion and research.
Permutive provides an audience platform for publishers and advertisers that facilitates privacy safe media trading. Its technology operates on over one billion devices globally to support data driven advertising.
Permutive has secured £14m in Series B funding led by Octopus Ventures, with participation from EQT Ventures and earlier investors. The fresh capital will support the company as it expands its operations internationally, particularly growing its market share in North America. Additionally, the funds will be directed towards ongoing research and development efforts to help publishers successfully monetise their audience data amid changing industry regulations. This financing milestone follows a period of strong revenue growth and rising demand for privacy-compliant data infrastructure among major global publishers.
From the founder
"We’re really excited to announce this new milestone, which will help us to continue the momentum of helping publishers to understand and monetize their audiences. It’s our mission to reset advertising and to protect privacy while making data useful, and this funding will help us towards working for this goal."
Joe Root
CEO and co-founder at Permutive
Investor perspective
"Octopus Ventures is thrilled to step forward and invest further into what we see as a very special business with immense potential. When we first invested, board meetings were held in kitchens and the strategy had to be agile in order to refine the product and vision. Today, Permutive is the UK category leader in its field and is beating billion-dollar global businesses on a consistent basis in trial processes. The team has hired many incredible people and is now ready to replicate the success seen in the UK in the US. Given the evolving regulatory and customer priorities, Permutive’s technology could be genuinely pioneering in its field."
Will Gibbs
Healthtech Partner, Octopus Ventures
Use of funds
- 01Expand into international markets
- 02Fund research and development
